Skip to content

A Study for Discovering Biomarker Candidates of Idiopathic Parkinson's Disease - A Pilot Study

A Study for Discovering Biomarker Candidates of Idiopathic Parkinson's Disease - A Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004717
Enrollment
30
Registered
2020-02-07
Start date
2017-10-24
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Parkinson's disease (experimental group) -Those who have not been diagnosed with dementia among Parkinson's disease outpatients of Gil Medical Center Neurology -Criteria of UK Parkinson's Diseases Society Brain Bank Criteria -40 years old and over, total 15 people 2) Control group -Have no family history of movement disorder -Persons who do not meet other exclusion criteria -40 years old and over, total 15 people

Exclusion criteria

Exclusion criteria: 1) The following people are excluded from the experimental group • Pregnant women • Women who are currently breastfeeding • Patients with poor condition that are difficult to perform the test • Patients with brain diseases other than Parkinsonism • Persons deemed inappropriate by the clinical researcher in addition to the above items. 2) The following people are excluded from the control group. • Pregnant women • Women who are currently breastfeeding • Staff or students in the same institution • Patients with poor condition that are difficult to perform the test • Patients serious psychiatric problems • Patients with abnormal cognitive function due to the presence of central nervous system disease or sequelae of previous neurological diseases • Anyone with abnormal findings on brain MRI or PET in the past • Patients with brain diseases • Persons deemed inappropriate by the clinical researcher in addition to the above items.

Design outcomes

Primary

MeasureTime frame
RNA expression difference between the control and experimental groups

Secondary

MeasureTime frame
RNA expression profiling of samples

Countries

Korea, Republic of

Contacts

Public ContactSeung Yoon Nam

Gachon University Gil Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026